183 related articles for article (PubMed ID: 9700634)
1. Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection.
Colomina J; Gil MT; Codoñer P; Buesa J
J Med Virol; 1998 Sep; 56(1):58-65. PubMed ID: 9700634
[TBL] [Abstract][Full Text] [Related]
2. Serum IgA immune response to individual rotavirus polypeptides in young children with rotavirus infection.
Johansen K; Granqvist L; Karlén K; Stintzing G; Uhnoo I; Svensson L
Arch Virol; 1994; 138(3-4):247-59. PubMed ID: 7998832
[TBL] [Abstract][Full Text] [Related]
3. [Virus-specific serum and fecal antibodies response in children with acute rotavirus gastroenteritis].
Colomina J; Raga J; Gil MT; Buesa J
Enferm Infecc Microbiol Clin; 1998 Feb; 16(2):55-60. PubMed ID: 9586360
[TBL] [Abstract][Full Text] [Related]
4. Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.
Kirkwood CD; Boniface K; Richardson S; Taraporewala ZF; Patton JT; Bishop RF
J Med Virol; 2008 Jun; 80(6):1090-8. PubMed ID: 18428132
[TBL] [Abstract][Full Text] [Related]
5. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.
Feng N; Lawton JA; Gilbert J; Kuklin N; Vo P; Prasad BV; Greenberg HB
J Clin Invest; 2002 May; 109(9):1203-13. PubMed ID: 11994409
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus vaccination and infection induce VP6-specific IgA responses.
Lappalainen S; Blazevic V; Malm M; Vesikari T
J Med Virol; 2017 Feb; 89(2):239-245. PubMed ID: 27431308
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to individual rotavirus proteins following heterologous and homologous rotavirus infection in mice.
Ishida SI; Feng N; Gilbert JM; Tang B; Greenberg HB
J Infect Dis; 1997 Jun; 175(6):1317-23. PubMed ID: 9180169
[TBL] [Abstract][Full Text] [Related]
9. NSP4 antibody levels in rotavirus gastroenteritis patients with seizures.
Yeom JS; Kim YS; Jun JS; Do HJ; Park JS; Seo JH; Park ES; Lim JY; Woo HO; Park CH; Youn HS
Eur J Paediatr Neurol; 2017 Mar; 21(2):367-373. PubMed ID: 27847298
[TBL] [Abstract][Full Text] [Related]
10. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
11. Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.
Ishida S; Feng N; Tang B; Gilbert JM; Greenberg HB
J Clin Microbiol; 1996 Jul; 34(7):1694-700. PubMed ID: 8784572
[TBL] [Abstract][Full Text] [Related]
12. Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique.
Richardson SC; Grimwood K; Bishop RF
J Clin Microbiol; 1993 Feb; 31(2):377-85. PubMed ID: 8381813
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
14. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
15. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
Iosef C; Chang KO; Azevedo MS; Saif LJ
J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
[TBL] [Abstract][Full Text] [Related]
16. Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus.
Richardson SC; Bishop RF
J Clin Microbiol; 1990 Sep; 28(9):1891-7. PubMed ID: 2172292
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity patterns based on antibody reactivity to rotavirus antigens in Brazilian children under 5 years of age.
Andrade GP; Lima LR; Hoshino-Shimizu S; Oliveira MI; Mendonça RZ; Hársi CM; Stewien KE
J Med Virol; 1996 Jul; 49(3):212-7. PubMed ID: 8818967
[TBL] [Abstract][Full Text] [Related]
18. Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.
Cowley D; Pavlic D; Bogdanovic-Sakran N; Boniface K; Kirkwood CD; Bines JE
Hum Vaccin Immunother; 2018; 14(8):2082-2087. PubMed ID: 29688121
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.
Burns JW; Siadat-Pajouh M; Krishnaney AA; Greenberg HB
Science; 1996 Apr; 272(5258):104-7. PubMed ID: 8600516
[TBL] [Abstract][Full Text] [Related]
20. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]